e-learning
resources
Madrid 2019
Monday, 30.09.2019
Clinical approach to asthma management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of anti-IL5 treatment on symptoms of chronic rhinosinusitis, otitis and hearing loss in patients with severe eosinophilic asthma
M. Wiegman (Leeuwarden, Netherlands), J. Kroes (Leeuwarden, Netherlands), A. Van Der Meer (Leeuwarden, Netherlands), R. Gijtenbeek (Leeuwarden, Netherlands), K. De Jong (Leeuwarden, Netherlands), A. Ten Brinke (Leeuwarden, Netherlands)
Source:
International Congress 2019 – Clinical approach to asthma management
Session:
Clinical approach to asthma management
Session type:
Thematic Poster
Number:
2715
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Wiegman (Leeuwarden, Netherlands), J. Kroes (Leeuwarden, Netherlands), A. Van Der Meer (Leeuwarden, Netherlands), R. Gijtenbeek (Leeuwarden, Netherlands), K. De Jong (Leeuwarden, Netherlands), A. Ten Brinke (Leeuwarden, Netherlands). Effect of anti-IL5 treatment on symptoms of chronic rhinosinusitis, otitis and hearing loss in patients with severe eosinophilic asthma. 2715
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Effects of therapy for rhinosinusitis in signs and symptoms of asthma in children
Source: Eur Respir J 2007; 30: Suppl. 51, 383s
Year: 2007
Impact of chronic rhinosinusitis on clinical presentation in patients with asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 238s
Year: 2006
Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020
Omalizumab treatment reduces asthma exacerbations in children with moderate or severe persistent asthma
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017
Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema
Source: Eur Respir J 2001; 17: 596-603
Year: 2001
Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017
Effect of mepolizumab on chronic rhinosinusitis symptoms and nasal hypersensitivity in patients with or without nasal polyps
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020
Chronic paranasal sinusitis exacerbates allergic inflammation in patients with asthma and contributes to refractoriness to treatment
Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2012
Treatment of bronchial asthma and wheezing disorders: chronic
Source: ERS Skills Course 2016
Year: 2016
Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
Eosinophilic refractory inflammation in OCS-dependent severe asthma
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021
The impact of targeted therapy in children with uncontrolled allergic persistent severe asthma and nasal polyps
Source: International Congress 2017 – Paediatric asthma: therapies and comorbidities
Year: 2017
Late-onset persistent eosinophilic severe asthma
Source: International Congress 2015 – Severe asthma phenotyping
Year: 2015
Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Treatment of bronchial asthma and wheezing disorders: acute
Source: ERS Skills Course 2016
Year: 2016
Nocturnal respiratory symptoms in patients with chronic rhinosinusitis
Source: Annual Congress 2009 - Diagnostic aspects in obstructive sleep apnoea
Year: 2009
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis
Source: Eur Respir J 2001; 17: 1112-1119
Year: 2001
Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV
1
in patients with severe persistent allergic asthma irrespective of age
Source: Eur Respir J 2005; 26: Suppl. 49, 48s
Year: 2005
Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other?
Source: Eur Respir J 2003; 22: 8-13
Year: 2003
Pathophysiology of non-eosinophilic severe asthma
Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept